Perspective of Molecular Hydrogen in the Treatment of Sepsis

Author:

Qi Bo1,Yu Yang1,Wang Yaoqi1,Wang Yuzun1,Yu Yonghao1,Xie Keliang1

Affiliation:

1. Department of Anesthesiology, Tianjin Institute of Anesthesiology, Tianjin Medical University General Hospital, Tianjin 300052, China

Abstract

Sepsis is the main cause of death in critically ill patients with no effective treatment. Sepsis is lifethreatening organ dysfunction due to a dysregulated host response to infection. As a novel medical gas, molecular hydrogen (H2) has a therapeutic effect on many diseases, such as sepsis. H2 treatment exerts multiple biological effects, which can effectively improve multiple organ injuries caused by sepsis. However, the underlying molecular mechanisms of hydrogen involved in the treatment of sepsis remain elusive, which are likely related to anti-inflammation, anti-oxidation, anti-apoptosis, regulation of autophagy and multiple signaling pathways. This review can help better understand the progress of hydrogen in the treatment of sepsis, and provide a theoretical basis for the clinical application of hydrogen therapy in sepsis in the future.

Funder

National Natural Science Foundation of China

Science and Technology Support Key Program Affiliated to the Key Research and Development Plan of Tianjin Science and Technology Project

Natural Science Foundation of Tianjin

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,Pharmacology

Reference100 articles.

1. Singer M.; Deutschman C.S.; Seymour C.W.; Shankar-Hari M.; Annane D.; Bauer M.; Bellomo R.; Bernard G.R.; Chiche J.D.; Coopersmith C.M.; Hotchkiss R.S.; Levy M.M.; Marshall J.C.; Martin G.S.; Opal S.M.; Rubenfeld G.D.; van der Poll T.; Vincent J.L.; Angus D.C.; The third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016,315(8),801-810

2. Cecconi M.; Evans L.; Levy M.; Rhodes A.; Sepsis and septic shock. Lancet 2018,392(10141),75-87

3. Rudd K.E.; Johnson S.C.; Agesa K.M.; Shackelford K.A.; Tsoi D.; Kievlan D.R.; Colombara D.V.; Ikuta K.S.; Kissoon N.; Finfer S.; Fleischmann-Struzek C.; Machado F.R.; Reinhart K.K.; Rowan K.; Seymour C.W.; Watson R.S.; West T.E.; Marinho F.; Hay S.I.; Lozano R.; Lopez A.D.; Angus D.C.; Murray C.J.L.; Naghavi M.; Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet 2020,395(10219),200-211

4. Fleischmann C.; Scherag A.; Adhikari N.K.J.; Hartog C.S.; Tsaganos T.; Schlattmann P.; Angus D.C.; Reinhart K.; assessment of global incidence and mortality of hospital-treated sepsis. current estimates and limitations. Am J Respir Crit Care Med International forum of acute care trialists2016,193(3),259-272

5. Abe T.; Ogura H.; Shiraishi A.; Kushimoto S.; Saitoh D.; Fujishima S.; Mayumi T.; Shiino Y.; Nakada T.A.; Tarui T.; Hifumi T.; Otomo Y.; Okamoto K.; Umemura Y.; Kotani J.; Sakamoto Y.; Sasaki J.; Shiraishi S.I.; Takuma K.; Tsuruta R.; Hagiwara A.; Yamakawa K.; Masuno T.; Takeyama N.; Yamashita N.; Ikeda H.; Ueyama M.; Fujimi S.; Gando S.; Characteristics, management, and in-hospital mortality among patients with severe sepsis in intensive care units in Japan: the FORECAST study. Crit Care JAAM FORECAST group2018,22(1),322

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3